TG Therapeutics, Inc. (TGTX)
31.49
+2.72
(+9.45%)
USD |
NASDAQ |
Mar 17, 16:00
31.49
0.00 (0.00%)
After-Hours: 16:21
TG Therapeutics Market Cap : 5.029B for March 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Precision BioSciences, Inc. | 171.11M |
| Amicus Therapeutics, Inc. | 4.514B |
| Geron Corp. | 1.038B |
| MannKind Corp. | 842.65M |
| Arcus Biosciences, Inc. | 2.831B |
Market Cap Related Metrics
| PE Ratio | 11.34 |
| PS Ratio | 8.248 |
| PEG Ratio | 0.0060 |
| Price to Book Value | 7.760 |
| Price | 31.49 |
| Earnings Yield | 8.82% |
| PEGY Ratio | 0.0060 |
| Operating PE Ratio | 41.22 |
| Normalized PE Ratio | 11.33 |